(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2...ia have been forbidden to use Botox injections, fo... harmful substances. // The National Fatwa Counci...f the drug for treating medical conditions such as... it must be used only when a specialist deems the ...
...ted that the Agriculture and Health ministers from...ttending a meeting organized by the World Health//...keswoman says the focus is on controlling bird flu...ommunities. It has been reported that in Indonesia...
...ent said that it will not sue the US pharmaceutica...d hepatitis C contaminated blood and plasma// prod...e hemophiliac society suffer from sporadic bleedin...e organs, requiring regular transfusions of blood-...
... Ltd today said it has received approval from Drug...se I clinical trials on its New Molecular Entity//...-clinical studies on 'ZY H2' displayed that it has...stance and lower blood glucose in diabetic conditi...
Other Medicine News:(Date:9/4/2008)...e/ -- Axentis Pharma AG has,initiated a clinical p...ty,of a new therapeutic formulation for the treatm...is patients. The new formulation allows an,establi... the site of,infection. The forthcoming trial will...f the new drug. Initial results are expected in su...
(Date:9/3/2008)...re-FirstCall/ --,Pharmaceutical company Pharmaxis ...as enrolled the first subject into its second pivo...n cystic fibrosis sufferers., The Phase 3 trial i...rica, Argentina and Germany, and is the final clin...t Bronchitol for cystic fibrosis in the,United Sta...
(Date:9/3/2008)...se Awareness Month, CHARLOTTESVILLE, Va., Sept. 3...clinical-stage drug-development company commercial... needs, announced today that it has begun,to enrol...ead drug,candidate trans sodium crocetinate (TSC)....trials.gov Website, is investigating TSC as a trea...
(Date:9/3/2008)...aunch Progress and Adlea R...all Today at 11:30 am ET, SOUTH SAN FRANCISCO, Ca...nc. (Nasdaq: ANSV ) announced today that the comp...cial and late-stage product development to,acceler...ain management,company. The company also provided ...
Breaking Medicine Technology:Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Novel Angiogenic Drugs Including a Future Blockbuster from Genzyme Could Revolutionize Treatment of Peripheral Arterial Disease 492 1Novel Angiogenic Drugs Including a Future Blockbuster from Genzyme Could Revolutionize Treatment of Peripheral Arterial Disease 492 2Study Shows Plasma Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery 241 1Study Shows Plasma Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery 241 2Study Shows Plasma Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery 241 3RAND researchers offer options to improve immigrant health care quality access 963 1RAND researchers offer options to improve immigrant health care quality access 963 2Was ability to run early mans Achilles heel 3F 338 1Was ability to run early mans Achilles heel 3F 338 2Was ability to run early mans Achilles heel 3F 338 3...GUEL, Calif.--(BUSINESS WIRE)--Apr 26, 2007 - Aeol...day the publication*,in the April 18, 2007 issue o...rs at the University of Colorado and National Jewi...the Company,s first,orally available catalytic ant... in an animal model of Parkinson,s disease ("PD")....
...le="MARGIN: 0in 0in 0pt; TEXT-ALIGN: left; tab-sto...0in 0pt; tab-stops: list .5in; mso-list: l1 level1...Y: ,News Gothic MT,; mso-bidi-font-weight: bold">,...enefits of adding,Diovan to conventional therapy ...s: list .5in; mso-list: l1 level1 lfo2">, <span st...
Other Medicine Technology:Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 8Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 9Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 10Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 11Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 12The MediLive ImageBox is the first, easy-to-use digital,recording device that integrates with the surgical microscope and video camera., ,It simplifies image capturing by burning the still imag
With MediLive MindStream you can make, cut and edit digital videos, add commentaries and notes, and save them. MediLive MindStream - intuitive user interface and high-resolution monitor all in one.
The VISUCAM non-mydriatic fundus camera increases the quality and simplicity of fundus imaging. Compact, yet big enough to set the standard in ophthalmic photography, it features a unique combination
...er Monitoring System, equipped with the latest Epi...is algorithm, Heart Rate Variability analysis and ...ith an Epicardia System in place have complete con...t their needs, and managing their data. The Epicar...
Medicine Products: